This study demonstrates the diagnostic and prognostic value of PVR (gene expression and serum protein levels), serum amylase, and urinary biomarkers (IGFBP-7 and TIMP-2) in multiple myeloma (MM). This evidence concerns the gene IGFBP7 and Miyoshi myopathy.